Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
539
Frequently Asked Questions
What is Market Cap of Standard BioTools Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Standard BioTools Inc market cap is $888.67M.
What is the 52-week high for Standard BioTools Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Standard BioTools Inc 52 week high is $3.16 as of June 08, 2024.
What is the 52-week low for Standard BioTools Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Standard BioTools Inc 52 week low is $1.57 as of June 08, 2024.
What is Standard BioTools Inc stock price today?
Standard BioTools Inc stock price today is $2.32.
What was Standard BioTools Inc stock price yesterday?
Standard BioTools Inc stock price yesterday was $2.52.
What is the PE ratio of Standard BioTools Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Standard BioTools Inc’s P/E ratio is -2.33.
What is the Price-to-Book ratio of Standard BioTools Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Standard BioTools Inc P/B ratio is 1.5287.
What is Standard BioTools Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Standard BioTools Inc's EBITDA is -6.13.
What is the 50-day moving average of Standard BioTools Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Standard BioTools Inc 50-day moving average is $2.57.
How many employess does Standard BioTools Inc has?